Abstract-Various novel 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins have been synthesized by reaction of 6-(N-alkylanilino)-2-methylthiopyrimidin-4(3H)-ones with Vilsmeier reagent. The similar 2-(N-substituted amino) derivatives were prepared by nucleophilic replacement reaction of the 2-methylthio moiety by appropriate amines. The 2-oxo derivatives (i.e., 5-deazaflavins) were obtained by acidic hydrolysis of the 2-methylthio derivatives. The antitumor activities against CCRF-HSB-2 and KB cells and the antiviral activities against HSV-1 and HSV-2 have been investigated in vitro, and many compounds showed promising antitumor activities.
Introduction
Design and synthesis of 5-deazaflavin and flavin analogs as potential cancer chemotherapeutic agents have been in progress in our laboratory. [1] [2] [3] [4] [5] [6] Recently, we have reported the significant potential antitumor activities of 10-substituted 2-deoxo-2-phenyl-5-deazaflavins and flavin-5-oxides against NCI-H 460, HCT 116, A 431, CCRF-HSB-2 and KB cells (Scheme 1). 1 5-Amino-5-deazaflavins also revealed antiproliferative activity against L1210 and KB cells. 7 10-Aryl-5-deazaflavin derivatives were preliminarily reported to act as inhibitors against E3 activity of HMD2 in tumors that retain wide-type P53. 8 Actually, 5-deazaflavins have attracted great interest because of their homologues as potential riboflavin antagonists, bio-reductive cofactors for the naturally occurring flavins, for example, F 420 , and potent antitumor agents. 9 The role of tyrosine kinase in the control of cellular growth and differentiation is central to all organisms and the tyrosine kinase has been found to participate in human neoplastic diseases. Tyrosine kinase inhibitors and their potentials in the clinical applications are well documented by dramatic examples such as Gleevec, Iressa and Herceptin. Several tyrosine kinase inhibitors are undergoing human trials and several are in the pipeline of drug discovery. 10 Molecular docking has been a focus of attention for many years. Generally speaking, today's flexible docking programs such as AutoDock are able to predict protein-ligand complex structures with reasonable accuracy and speed. 11 One of the most reliable, robust and popular energy-based docking packages is AutoGrid/AutoDock because it allows a very efficient docking of flexible ligands (e.g. substrates, drug candidates, inhibitors, peptides, etc.) onto receptors (e.g. enzymes,
antibodies, nucleic acids, etc.). 12 Despite the large number of publications on chemistry of 5-deazaflavin and related compounds, the information of 2-methylthio-and 2-(N-substituted amino)-2-deoxo-5-deazaflavins is none yet. The above circumstances led us to seek a convenient synthetic route to the 2-methylthio-and 2-(N-substituted amino)-2-deoxo-5-deazaflavins to search their potential antitumor activities. In this study, we describe the facile synthesis of 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins as key compounds for antitumor active derivatives. These compounds were used as versatile intermediates for synthesis of the various amino coupling derivatives by nucleophilic substitution between 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins and suitable primary and secondary alkylamines.
group by appropriate amines for the purpose of syntheses of 2-amino-and 2-(substituted amino)-10-alkyl-2-deoxo-5-deazaflavins {2-amino-and 2-(substituted amino)-10-alkylpyrimido[4,5-b]quinolin-4(10H)-ones}
(3a-e, 4a-c, 6 , and 7a-q) as shown in Scheme 3. Namely, 10-alkyl-2-deoxo-2-dimethylamino-5-deazaflavins (3a-e) were prepared by heating the suitable 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2) with aqueous dimethylamine in a stainless steel sealed vessel at 135 °C for 4 h to afford the corresponding products as yellow needles in 59-96 % yields. Whereas, the 10-alkyl-2-amino-2-deoxo-5-deazaflavins (4a-c) were prepared by fusion of the suitable 2 with ammonium acetate at 160-165 °C for 0.5-3 hours to afford the corresponding products as yellow needles in 57-77 % yields. A similar treatment of 2-deoxo-10-methyl-2-methylthio-5-deazaflavin (2a) with n-butylammonium acetate (prepared in situ) at 150-165 °C for 1-3 hours resulted in the formation of 2-n-butylamino-2-deoxo-10-methyl-5-deazaflavin (6) as a yellow crystalline solid in 91 % yield.
Moreover, a variety of 2-(substituted amino)-10-alkyl-2-deoxo-5-deazaflavins (7a-q) were prepared by the facile method involving reflux of compound 2 with an appropriate morpholine, piperidine, N-methylpiperazine, N-methyl-N-ethanolamine, ethanolamine, or n-octylamine in n-butanol for 2-5 h. All products 7a-q were obtained as bright yellow needles in quite good yields of 70-99 %. For all the above mentioned reactions which involve treatment with different amines, the excess volatile amines were removed by concentration in vacuo.
Whereas, the amines of high boiling point were removed by leaching from the residue with water or ethanol for piperidine, morpholine, N-(2-hydroxyethyl)-N-methylamine, and N-methylpiperazine, and petroleum ether for n-octylamine to get the amine-free products. Acidic hydrolysis of some 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2) in 5N hydrochloric acid by heating under reflux for 1-2 h gave the corresponding 10-alkyl-5-deazaflavins (5a-c) as yellow needles in 78-91% yields as shown in Scheme 3.
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UV-vis, IR, and NMR spectra and elemental analyses were used for determination and identification of the newly assigned structures. The structures of the key intermediates 1a-j were confirmed in particular by the presence of a proton resonance at the 5-position as a singlet signal at 4.62-5.08 ppm in 1 H NMR spectra. The cyclized 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2a-j) showed a characteristic singlet signal due to the C 5 -proton in the lower field at 9.09-9.63 ppm. It is implying that the methine at the 5-position of 2a-j is more 6 electron-deficient than the other methines. Any substituent at the benzene ring led this singlet signal of the C 5 -proton to the slight upfield, except for 2j (2-deoxo-6,9-dimethoxy-10-methyl-2-methylthio-5-deazaflavin), which exhibits this signal in more downfield at 9.63 ppm. This can be explained by the possible formation of a hydrogen bond between the oxygen atom of 6-OMe moiety and the proton at the 5-position. This suggestion is supported by the similar effect between 9-OMe group and the N 10 -methyl moiety of 2j, that is, the chemical shift of methyl group at the 10-position shown in more downfield region at 4.48 ppm in comparison with N 10 -methyl moieties of other derivatives appeared in the range of 4.21-4.35 ppm. This effect was also clearly observed in the UV spectrum of 2j, which indicated some hypsochromic shift, compared with other spectra of 2. Considering the 1 H NMR spectra, the 2-deoxo-5-deazflavin derivatives (3-7) are characterized by disappearance of the strong characteristic singlet signal of the 2-methylthio group, which were assigned for compounds 2a-j at 2.56-2.63 ppm.
The 2-(substituted amino) derivatives (3, 4, 6, and 7) and 5-deazaflavins (5) showed a characteristic singlet signal of the C 5 -proton in the lower field at 8.77-9.12 and 8.93-9.0 ppm, respectively. The methine protons (8.77-9.12 ppm) at 5-position for 3, 4, 6, and 7 showed in upper field than those (9.09-9.63 ppm) of 2a-j, due to the higher electron donating properties of the 2-(substituted amine) groups in comparison with that of the 2-methylthio group.
Regarding the 1 H NMR of 10-alkyl-2-deoxo-2-dimethylamino-5-deazaflavins (3a-e), it was noticed that the N 10 -methyl derivatives (3a,c-e) exhibited the equivalent N 2 -dimethyl groups as an equivalent singlet signal of 6H integral almost at 3.33 ppm. Whereas, the N 10 -ethyl derivative (3b) exhibited the nonequivalent N 2 -dimethyl groups as two singlet signals at 3.34 and 3.48 ppm due to the steric hindrance of longer chain of ethyl group at the N-10 position.
Interestingly, the phenomenon of reversible interconversion of two isomers at 27 °C in case of the 2-monoalkyl-7 amino (secondary amino) derivatives (6 and 7p,q) was observed as tautomerism in 1 H NMR spectra. The twin overlapped spectra of approximately (1:2 or 2:1) ratio of the 2-monoalkylamino and 2-monoalkylimino tautomers in (CD 3 ) 2 SO were obtained for the two resonance species (tautomers). Especially, such duplicated spectra were observed in the range of 4.0-9.0 ppm based on the tautomers of the guanidine adjacent to carbonyl group. At higher temperature of 90-100 °C, the coalescence of the duplicated spectrum was observed to produce the single spectrum. As indicated in Figure 1 (A) for compound 6, the 1 H NMR spectrum at 27 °C exhibited two singlet signals of C 5 -H and N 10 -Me at 8.81 and 8.87 ppm and at 4.05 and 4.14 ppm, respectively, and other protons at 6, 7,
8, and 9-positions were also dupulicated. On the other hand, in the case of 100 °C, the singlet signal at 8.80 and 4.07 ppm, which was attributable to the C 5 -H and N 10 -Me, respectively, was appeared as shown Figure 1 (B) and the duplicated spectral signals for other protons also coalesced. The 2-n-butylimino tautomer is proposed predominantly at higher temperature because it has a heat of formation (PM3-Mozyme) of 36.23 kcal/mol which is higher than that of 2-butylamino tautomer (16.95 kcal/mol). This phenomenon is mainly attributed to the presence of a secondary amine at the 2-position, whereas it does not take place in case of 2-substiuted primary and teriary amines, for example. compounds 4a-c and 7a-o, respectively.
The structural identity of the prepared compounds was verified by UV-vis absorption spectra. The spectra for 8 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2a-j) located in shorter wavelength region in comparison with those for previously reported 2-deoxo-2-phenyl-5-deazaflavin derivatives, 1 which have more conjugated ring system. The UV absorption spectra of the 6-(N-alkylanilino)-2-methylthiopyrimidin-4(3H)-ones (1a-j) showed one absorption maximum at 239-246 nm together with two absorption shoulders at 259-275 and 287-293 nm.
Whereas, the tricyclic 5-deazaflavins (2a-j) showed five absorption maxima at 213-231, 259-275, 278-291, 311-351 and 403-450 nm. The absorption band at 259-275 nm was shown as a maximum absorption peak or a shoulder. Compound 2j indicated the characteristic blue shift (hypsochromic shift) in all wavelength regions in comparison with those of 2a-i. This may be attributed to the hydrogen bond formation between the oxygen atom of 6-OMe moiety and C 5 -proton of 2j. This hinders the delocalization of the lone pair on oxygen of 6-OMe to the ring system by the hydrogen bond. The UV spectra of 2-(substituted amino)-10-alkyl-2-deoxo-5-deazaflavins (3, 4, 6, and 7) showed five absorption maxima at 220-225, 268-288, 318-326, 407-428 and 424-454 nm, together with an absorption shoulder at 383-404 nm, except for compound 7n. All 5-deazaflavin analogs (2-7) showed yellow color owing to the presence of absorption maximum at 400-440 nm in the longest wavelength. Generally, the UV spectra of 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2) exhibited longer wavelength than those of 2-(substituted amino)-10-alkyl-2-deoxo-5-deazaflavins and 5-deazaflavins (3-7) as represented in Figure 2 for compounds 1a, 2a, 5a, and 7a. This is attributed to the S-atom which causes a generally red shift (bathochromic shift) in the spectrum due to its easier polarizability, 20 Thus, the spectum of 2-deoxo-10-methyl-2-methylthio-5-deazaflavin (2a) exhibited the bathochromic shift of ca. 20 nm longer wavelength than that of 5-deazflavin (5a) in all UV and visible regions.
In vitro antitumor activities of 5-deazaflavins and their 2-(N-substituted amino) derivatives against human tumor cell lines
The compounds (2-5 and 7) synthesized in this study were tested in vitro for their growth inhibitory activities against two human cultured tumor cell lines, that is., human T-cell acute lymphoblastoid leukemia cell line (CCRF-HSB-2) and human oral epidermoid carcinoma cell line (KB). The antitumor agent, cytosine arabinoside (Ara-C), was used as positive control.
As can be seen in Table 1 , although all compounds of 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2) and 10-alkyl-2-deoxo-2-dimethylamino-5-deazaflavins (3) were inferior antitumor activities compared to Ara-C, they have been found to show significant antitumor activities against CCRF-HSB-2 cell line. Among them, the compounds 2a,h, 3b and 4b indicated better activities of less than 2.0 µg/mL (IC 50 ). Against KB cell line they exhibited good growth inhibitory activities of about one-tenth antitumor potency of Ara-C (IC 50 : 0.23 µg/mL), that is, the IC 50 of compounds 2a,h, 3b, and 4b were 1.97, 1.73, 3.96 and 1.00 µg/mL, respectively. The 2-deoxo-5-deazaflavins may reveal fairly good and less toxic antitumor activities in comparison with Ara-C.
Moreover, compounds 2b,f,i,j, 6, and 7h,l,n exhibited reasonable potential growth inhibitory activities of ca. The most straightforward method for validation of the used scoring function is to inspect how closely the bestdocked conformation resembles the bound ligand in the experimental crystal structure. As cited in literature, 10 if the RMSD (root mean square deviation) of the best docked conformation is ≤2.0 Å from the experimental one, the used scoring function is successful. Therefore, the validation of the function implemented in AutoDock was done by docking of the native ligand into its binding site. The docked results were compared to the crystal structure of the bound ligand-protein complex. The obtained success rates of AutoDock 24 were highly excellent as shown in Table 2 . These compounds include 7-substituted 2-deoxo-10-methyl-2-dimethylamino-5-deazaflavins (3d,e), 10-alkyl-2-amino-2-deoxo-5-deazaflavins (4a-c), 2-(substituted amino)-10-alkyl-2-deoxo-5-deazaflavins (7c,e,n,p,q), and the computationally designed 2-deoxo-5-deazaflavins connected with amino acids (8a,b). The later derivatives exhibited many hydrogen bonds (4-6) between the target PTK. As shown in Table 2 
Conclusions
In this study, various novel 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2a-j) were synthesized from 6-(N-monoalkylanilino)-2-methylthiopyrimidin-4(3H)-ones (1a-j) by the reaction using Vilsmeier reagent. The similar 2-(substituted amino)-10-alkyl-2-deoxo-5-deazaflavins (3a-e, 6, and 7a-q) were synthesized by the facile replacement of C 2 -methylthio moiety by amines of different type. 10-Alkyl-2-amino-2-deoxo-5-deazaflavins UV spectra were measured in absolute EtOH using Beckman DU-68S UV spectrophotometer and the wavelength value with sh refer to wavelength at which shoulder or inflexion occur in the absorption. All reagents were of commercial quality and were used without further purification. Organic solvents were dried in the presence of an appropriate drying agent and were stored over suitable molecular sieves. Reaction progress was monitored by analytical thin layer chromatography (TLC) on pre-coated glass plates (silica gel 60F 254 -plate-Merck) and the products were visualized by UV light.
General procedure for the preparation of 6-(N-alkylanilino)-2-methylthiopyrimidin-4(3H)-ones (1a-j).
A mixture of 6-chloro-2-methylthiopyrimidin-4(3H)-one 14,16 (3.0 g, 0.017 mol) and an appropriate N-alkylaniline (0.051-0.085 mol) in n-butanol (20 mL) was refluxed with stirring for 12-72 h. After cooling, the precipitated solid was filtered off to get the first crop. The filtrate was concentrated in vacuo and the residue was crushed with diethyl ether to precipitate powdery crystals, which were filtered off, washed with water, and dried to afford the second crop. The collected solids were crystallized from appropriate solvents with charcoal to afford the corresponding products as colorless needles in 55-83 % yields.
6-(N-Methylanilino)-2-methylthiopyrimidin-4(3H)-one (1a).
Yield 
6-(N-Ethylanilino)-2-methylthiopyrimidin-4(3H)-one (1b).
6-(N-Methyl-4-methylanilino)-2-methylthiopyrimidin-4(3H)-one (1c).
6-(N-Methyl-2-methylanilino)-2-methylthiopyrimidin-4(3H)-one (1d).
6-(N-Ethyl-4-methylanilino)-2-methylthiopyrimidin-4(3H)-one (1h).
4.1.12.
General procedure for the preparation of 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins
{10-alkyl-2-methylthiopyrimido[4,5-b]quinolin-4(10H)-ones} (2a-j).
A mixture of 6-(N-alkylanilino)-2-methylthiopyrimidin-4(3H)-ones (1, 0.01 mol) and phosphoryl chloride (7.7 g, 0.05 mol) in anhydrous dimethylformamide (10 mL) was heated under stirring at 90 °C for 0.5-2 h. Then, the reaction mixture was poured onto ice and neutralized with aqueous ammonia (pH 7). The yellow crystals separated were filtered off, washed with water, dried and recrystallized from an appropriate solvent to afford the corresponding product as yellow needles in 71-99 % yields.
10-Methyl-2-methylthiopyrimido[4,5-b]quinolin-4(10H)-one (2a).
10-Ethyl-2-methylthiopyrimido[4,5-b]quinolin-4(10H)-one (2b).
7,10-Dimethyl-2-methylthiopyrimido[4,5-b]quinolin-4(10H)-one (2c).
9,10-Dimethyl-2-methylthiopyrimido[4,5-b]quinolin-4(10H)-one (2d).
Yield, ( 
7-Methoxy-10-methyl-2-methylthiopyrimido[4,5-b]quinolin-4(10H)-one (2e).
7-Chloro-10-methyl-2-methylthiopyrimido[4,5-b]quinolin-4(10H)-one (2g).
10-Ethyl-7-methyl-2-methylthiopyrimido[4,5-b]quinolin-4(10H)-one (2h).
7,8,10-Trimethyl-2-methylthiopyrimido[4,5-b]quinolin-4(10H)-one (2i).
General procedure for the preparation of 10-alkyl-2-deoxo-2-dimethylamino-5-deazaflavins

{10-alkyl-2-dimethylaminopyrimido[4,5-b]quinolin-4(10H)-ones} (3a-e)
A mixture of 10-alkyl-2-deoxo-2-methylthio-5-deazaflavin (2, 5.0 mmol) and 50% aqueous dimethylamine (50 mL) was heated in steel sealed tube at 135 °C (10 kg/cm 2 pressure) for 4 h. After the reaction was complete, the precipitated crystals were collected by filteration, and mother liquid was evaporated in vacuo to get the second crop. The product was washed with water, dried and recrystallized from an appropriate solvent to afford the corresponding product as yellow crystals in 59-96% yields.
10-Methyl-2-dimethylaminopyrimido[4,5-b]quinolin-4(10H)-one (3a).
10-Ethyl-2-dimethylaminopyrimido[4,5-b]quinolin-4(10H)-one (3b
7-Methoxy-10-methyl-2-dimethylaminopyrimido[4,5-b]quinolin-4(10H)-one (3c
7-Chloro-10-methyl-2-dimethylaminopyrimido[4,5-b]quinolin-4(10H)-one (3d).
4.1.29.
General procedure for the preparation of 10-alkyl-2-amino-2-deoxo-5-deazflavins
{10-alkyl-2-aminopyrimido[4,5-b]quinolin-4(10H)-ones} (4a-c)
A mixture of 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2, 4.0 mmol) and ammonium acetate (10 g, 0.13 mol) was heated under stirring at 160-165 °C for 0.5-3 h. The reaction mixture was cooled, diluted with water (15 mL), neutralized with aqueous ammonia (pH 7), and cooled in refrigerator overnight. The resulting yellow crystals were collected by filtration, dried and crystallized from an appropriate solvent to give the corresponding products as yellow needles in 57-77% yields.
2-Amino-10-methylpyrimido[4,5-b]quinolin-4(10H)-one (4a)
Yield, (0.64 g, 57%); mp 284-288 °C (decomp., from DMF, lit., 
quinoline-2,4(3H,10H)-diones} (5)
To 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2, 0.01 mol) was added 5N hydrochloric acid (250 mL). Then, the mixture was refluxed for 1-2 h and the resulting clear yellow solution was concentrated in vacuo. The yellow residue was crushed with water and neutralized with aqueous ammonia (pH 7). The precipitated powdery crystals were filtered off, washed well with water, dried and recrystallized from glacial acetic acid to afford the corresponding products as yellow needles in 78-91% yields.
10-Methylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione (5a)
Yield, (2.07 g, 91%); mp >300 °C (from HOAc, lit., 27 
10-Ethylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione (5b)
Yield, (2.20 g, 91%); mp >300 °C (from HOAc, lit., 
Preparation of 2-n-butylamino-10-methylpyrimido[4,5-b]quinolin-4-(10H)-one (6).
n-Butylammonium acetate was prepared in situ by slowly adding glacial acetic acid (5.7 mL, 0.1 mol) to n-butylamine (7.31g, 0.1 mol) in an ice bath. 2-Deoxo-10-methyl-2-methylthio-5-deazaflavin (2, 0.008 mol) was added to the n-butylammonium acetate and the mixture was fused under stirring at 150-165 °C for 1-3 h. After the reaction was complete, water (100 mL) was added to the mixture to give a turbid solution. The residue concentrated in vacuo was dissolved in hot water and brought to pH 8 with sodium bicarbonate to give a yellow crystalline solid, which was dried and recrystallized from DMF to afford yellow needles. 
2-[N-(2-Hydroxyethyl)-N-methylamino]-10-methylpyrimido[4,5-b]quinolin-4(10H)-one (7a).
Yield, ( The procedure was carried out using the modified MTT assay 28 to determine the inhibitory effects of test compounds on cell growth in vitro as mentioned in detail in our previous paper. 1 Two human tumor cell lines of human T-cell acute lymphoblastoid leukemia (CCRF-HSB-2) and human oral epidermoid carcinoma (KB) were used in this study.
10-Ethyl-2-[N-(2-hydroxyethyl)-N-methylamino]-7-methylpyrimido[4,5-b]quinolin-4-(10H)-one
10-Methyl-2-(4-methylpiperazinyl)pyrimido[4,5-b]quinolin-4-(10H)-one (7h
Molecular docking study
The advanced docking program AutoDock 3.0. state is lower than that of the old state, the new one is automatically accepted as the next step in docking.
Preparation of ligands and target protein tyrosine kinase
The compounds involved in this study as ligands include 10-alkyl-2-deoxo-2-methylthio-5-deazaflavins (2a-j), All bound waters, ligand were removed from the protein. For the target, the amino acids of the ligand binding site were defined using data in pdbsum http://www.ebi.ac.uk/thornton-srv/databases/pdbsum/ accessed on January 8,
2006
. The polar hydrogen model was chosen for the crystal structure. The proteins were assigned with Kollman-united charge. The polar hydrogens and charges were added.
Grid generation and run of molecular docking
The grid maps representing the native ligand in the actual docking target site were calculated with AutoGrid. The grids (one for each atom type in the ligand, plus one for electrostatic interactions) were chosen to be sufficiently large to include not only the active site but also significant portions of the surrounding surface. The three dimensional grids, 80 Å grid size (x, y, z) with a spacing of 0.375 Å, were created because the location of the native ligand in the crystal structure was known. The cubic grid box was centered in the catalytic active region and encompassed the binding site where the ligands were embedded. Then automated docking studies were carried out using AutoDock version 3.0.5. 24 Of the three different search algorithms offered by AutoDock, the GA-LS search algorithm (Genetic algorithm with local search) was chosen to search for the best conformers. The parameters were set using the software ADT (Autodock Tool Kit) on PC which is associated with Autodock 3.0.5 24. For all docking parameters, default values were used with 10 independent docking runs for each docking case.
Molecular modeling and analysis of the docked results
There are two kinds of free energies output by Autodock. One is the predicted binding free energy that includes the intermolecular energy and torsional free energy, and the other the docking energy that includes the intermolecular and intramolecular energies. The former is only reported at the end of a docking operation, while the latter is used for selecting better individuals of population during a docking run. 24 We used only the binding free energy of the first type as the criterion for ranking. Furthermore, the intermolecular hydrogen bonds, whose effect has already been counted in the binding energy, were also investigated in order to find useful information for drug design. A comparison of the results suggests that the binding free energy is more reliable as a criterion for the virtual screening via molecular docking. Cluster analysis was performed on the docked results using a root mean square (RMS) tolerance of 0. However, the more linear hydrogen bond is likely to be more stronger. 30 Moreover, there is general agreement that for carbonyl acceptors, the H … O=C angle is distributed around 120 o . Therefore, in our modeling results we consider the hydrogen bond angle ≥ 120° to be of a reasonable strength.
